Registered number
10781326
Shish Patel Pharma Consulting Ltd
Unaudited Filleted Accounts
31 May 2025
Shish Patel Pharma Consulting Ltd
Registered number: 10781326
Balance Sheet
as at 31 May 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 1,151 -
Current assets
Debtors 4 101 34
Cash at bank and in hand 30,881 32,740
30,982 32,774
Creditors: amounts falling due within one year 5 (20,500) (14,608)
Net current assets 10,482 18,166
Net assets 11,633 18,166
Capital and reserves
Called up share capital 10 10
Profit and loss account 11,623 18,156
Shareholders' funds 11,633 18,166
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Shishir Patel
Director
Approved by the board on 4 November 2025
Shish Patel Pharma Consulting Ltd
Notes to the Accounts
for the year ended 31 May 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Equipment etc
£
Cost
At 1 June 2024 3,583
Additions 1,295
Disposals (3,583)
At 31 May 2025 1,295
Depreciation
At 1 June 2024 3,583
Charge for the year 144
On disposals (3,583)
At 31 May 2025 144
Net book value
At 31 May 2025 1,151
4 Debtors 2025 2024
£ £
Other taxes and social security costs 101 34
5 Creditors: amounts falling due within one year 2025 2024
£ £
Other creditors 20,500 14,608
6 Controlling party
As at the balance sheet date, Shishir Patel is the controlling party by virtue of his shareholding.
7 Other information
Shish Patel Pharma Consulting Ltd is a private company limited by shares and incorporated in England. Its registered office is:
53 Marcliff Grove
Stockport
Cheshire
SK4 2AB
Shish Patel Pharma Consulting Ltd 10781326 false 2024-06-01 2025-05-31 2025-05-31 VT Final Accounts April 2025 Mr Shishir Patel No description of principal activity 10781326 2023-06-01 2024-05-31 10781326 core:WithinOneYear 2024-05-31 10781326 core:ShareCapital 2024-05-31 10781326 core:RetainedEarningsAccumulatedLosses 2024-05-31 10781326 2024-06-01 2025-05-31 10781326 bus:EntityNoLongerTradingButTradedInPast 2024-06-01 2025-05-31 10781326 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 10781326 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 10781326 bus:Director40 2024-06-01 2025-05-31 10781326 1 2024-06-01 2025-05-31 10781326 2 2024-06-01 2025-05-31 10781326 core:PlantMachinery 2024-06-01 2025-05-31 10781326 countries:England 2024-06-01 2025-05-31 10781326 bus:FRS102 2024-06-01 2025-05-31 10781326 bus:FilletedAccounts 2024-06-01 2025-05-31 10781326 2025-05-31 10781326 core:WithinOneYear 2025-05-31 10781326 core:ShareCapital 2025-05-31 10781326 core:RetainedEarningsAccumulatedLosses 2025-05-31 10781326 core:PlantMachinery 2025-05-31 10781326 2024-05-31 10781326 core:PlantMachinery 2024-05-31 iso4217:GBP xbrli:pure